Avinger, Inc. Stock

Equities

AVGR

US0537348775

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:30:00 2024-05-28 pm EDT 5-day change 1st Jan Change
2.27 USD -12.69% Intraday chart for Avinger, Inc. -23.05% -16.24%
Sales 2024 * 10.5M Sales 2025 * 13.93M Capitalization 4.43M
Net income 2024 * -16M Net income 2025 * -14M EV / Sales 2024 * 0.42 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 0.32 x
P/E ratio 2024 *
-0.08 x
P/E ratio 2025 *
-0.13 x
Employees 70
Yield 2024 *
-
Yield 2025 *
-
Free-Float 84.15%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.50%
1 week-13.22%
Current month-31.55%
1 month-32.10%
3 months-30.05%
6 months-14.95%
Current year-5.54%
More quotes
1 week
2.50
Extreme 2.5
3.04
1 month
2.50
Extreme 2.5
4.15
Current year
2.50
Extreme 2.5
5.45
1 year
2.50
Extreme 2.5
18.00
3 years
2.50
Extreme 2.5
438.00
5 years
2.50
Extreme 2.5
1 710.00
10 years
2.50
Extreme 2.5
1 000 000.00
More quotes
Managers TitleAgeSince
Founder 63 07-03-07
Chief Executive Officer 61 14-12-28
Director of Finance/CFO 41 19-12-31
Members of the board TitleAgeSince
Chief Executive Officer 61 14-12-28
Chairman 81 14-11-30
Director/Board Member 72 11-02-28
More insiders
Date Price Change Volume
24-05-28 2.27 -12.69% 66 142
24-05-24 2.6 -7.96% 28,476
24-05-23 2.825 -4.24% 16,786
24-05-22 2.95 0.00% 9,868
24-05-21 2.95 -3.28% 11,410

Delayed Quote Nasdaq, May 28, 2024 at 10:57 am EDT

More quotes
Avinger, Inc. is a commercial-stage medical device company. The Company designs, manufactures, and sells real-time, image-guided, minimally invasive catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). Its Lumivascular platform includes the Lightbox real-time imaging console, the Ocelot and Tigereye family of catheters, which are image-guided catheters designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and the Pantheris family of catheters, its image-guided atherectomy family of catheters designed to allow physicians to remove arterial plaque in PAD patients. Its Pantheris is a single-use product and provides physicians with the ability to see a cross-sectional view of the peripheral artery to guide the removal of blockages throughout the procedure. It has also developed a line extension of its Pantheris image-guided atherectomy platform, Pantheris Small Vessel (SV).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
2.6 USD
Average target price
5 USD
Spread / Average Target
+92.31%
Consensus